Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Perspectives on NASH Histology: Cellular Ballooning
Annals of Hepatology 16(2) (2017)
Stephen Hugh Caldwell; Carolin Lackner
The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3
Hepatitis Monthly 17(1) (2016)
Shahin Merat; Amir Houshang Sharifi; Arghavan Haj-Sheykholeslami; Hossein Poustchi; Babak Fattahi; Alireza Nateghi-Baygi; Seyed Moayed Alavian; Reza Malekzadeh
Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype 1 infection: a systematic review and meta-analysis
DARU Journal of Pharmaceutical Sciences 25(1) (2017)
Fardin Dolatimehr; Hamidreza Karimi‐Sari; Mohammad Saeid Rezaee Zavareh; Seyed Moayed Alavian; Bita Behnava; Mohammad Gholami Fesharaki; Heidar Sharafi
SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial
Clinical Infectious Diseases 70(10) (2019)
Shahin Merat; Shahin Merat; Amir‐Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour‐Ghanaei; Mohammad Reza Fattahi; Lida Ahmadi; Mohammad Hossein Somi; Hamid Kalantari; Mohammad Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyed Hamid Moosavy; Masood Ziaee; Mohammad Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Aliakbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Tirgar Fakheri; Mohammad Minakari; Hossein Sardarian; Adel F allah Ghajary; Mojtaba Fattahi Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Martin Hill; Reza Malekzadeh
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
Annals of Hepatology 16(2) (2017)
Mohammad Saeid Rezaee Zavareh; Khashayar Hesamizadeh; Bita Behnava; Seyed Moayed Alavian; Mohammad Gholami Fesharaki; Heidar Sharafi
Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
EBioMedicine 21 (2017)
Mostafa Yakoot; Alaa M. Abdo; Siham Abdel Rehim; Sherine Helmy
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Hepatitis Monthly 17(11) (2017)
Seyed Moayed Alavian; Heidar Sharafi
Highly sensitive and selective β-Ni(OH)2@CNTs modified electrode for detection of Anti-Hepatitis C
Microchemical Journal 215 (2025)
Melad Lotfallah Adolf; Mahmoud A. Hefnawy; Shymaa S. Medany; Eman Yossri Frag
High Efficiency and Safety of Hepatitis C Treatment Among People Who Inject Drugs in Vietnam
Journal of Viral Hepatitis 32(11) (2025)
Didier Laureillard; Nguyễn Thanh Bình; Vinh Vu Hai; Tran Thi Hong; Catherine Quillet; Nham Thi Tuyet Thanh; Roselyne Vallo; Bạch Thị Như Quỳnh; Jean‐Pierre Molès; Khuat Thi Hai Oanh; Dương Thị Hương; Delphine Rapoud; Jonathan P. Feelemyer; Laurent Michel; Peter T. Vickerman; Hannah Fraser; Laurence Weiss; Maud Lemoine; Karine Lacombe; Don Des Jarlais; Phạm Minh Khuê; Nicolas Nagot
Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
Digestive Diseases and Sciences 66(4) (2020)
Man‐Fung Yuen; Sze-Hang Liu; Wai‐Kay Seto; Lung‐Yi Mak; Shelby L. Corman; Danny Chung Hsu; Mary Y. K. Lee; Tsz Kin Khan; Amy Puenpatom
Research progress on the direct antiviral drugs for hepatitis C virus
BioScience Trends 11(1) (2017)
Jianjun Gao; Chuanxia Ju
Treatment of Hepatitis C Infection with Direct-Acting Antiviral Agents in Liver-Transplant Patients: A Systematic Review and Meta-Analysis
Hepatitis Monthly 17(6) (2017)
Mohammad Saeid Rezaee Zavareh; Khashayar Hesamizadeh; Heidar Sharafi; Seyed Moayed Alavian
Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia
Journal of Medical Virology 91(3) (2018)
Arezoo Khosravi; Hamidreza Karimi‐Sari; Mahdi Abedi‐Andani; Bita Behnava; Ali Namvar; Ali Anvar; Seyed Moayed Alavian
Pure component contribution (PCCA) and synergy interval partial least squares (siPLS) algorithms for efficient resolution and quantification of overlapped signals; an application to novel antiviral tablets of daclatasvir, sofosbuvir and ribavirin
European Journal of Chemistry 10(4) (2019)
Maha M. Abou El‐Alamin; Maha A. Sultan; Maha Abdel Monem Hegazy; Alastair W. Wark; Marwa Mohamed Mahmoud Azab
Letter: the efficacy of interferon‐free regimens in HCV ‐related Child C cirrhosis needs careful interpretation
Alimentary Pharmacology & Therapeutics 46(1) (2017)
Mohammad Saeid Rezaee Zavareh; Seyed Moayed Alavian
STABILITY-INDICATING REVERSE-PHASE HIGH- PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT FOR SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND DACLATASVIR IN PURE AND PHARMACEUTICAL FORMULATION
Asian Journal of Pharmaceutical and Clinical Research (2019)
SWETHA A; B. Ramya Kuber
Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial
Clinical Infectious Diseases 73(1) (2021)
Shahin Merat; Amir‐Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour‐Ghanaei; Mohammad Reza Fattahi; Lida Ahmadi; Mohammad Hossein Somi; Hamid Kalantari; Mohammad Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyed Hamid Moosavy; Masood Ziaee; Mohammad Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Aliakbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Tirgar Fakheri; Mohammad Minakari; Hossein Sardarian; Adel F allah Ghajary; Mojtaba Fattahi Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Martin Hill; Reza Malekzadeh
Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’
European Journal of Gastroenterology & Hepatology 30(7) (2018)
Seyed Moayed Alavian; Heidar Sharafi
Efficacy and safety of anti-Hepatitis C virus regimens containing daclatasvir: a systematic review and meta-analysis from Egypt
Egyptian Liver Journal 15(1) (2025)
Muhammad Abdel‐Gawad; Amro Metwaly Hassan; Ahmed Qasem Mohammed; Ashraf M. Al Kabeer; Eman Marwan; Mohamed M. Abd Elnaser; Mohamed Mahmoud El-Kassas